basic_info |
|
| Product_Name： | 辛伐他汀 |
| CAS： | 79902-63-9 |
| 中文同义词： | 西伐斯汀 ; 塞瓦停 ; 舒降脂 ; 辛伐他汀 |
| EnglishSynonyms： | 2,2-DIMETHYLBUTANOIC ACID 1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-[2-TETRAHYDRO-4-HYDROXY-2-OXO-2H-PYDRAN-YL]-1-NAPHTHALENYL ESTER ; MK-733 ; SIMVASTATIN ; BUTANOIC ACID, 2,2-DIMETHYL-, (1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENYL ESTER ; SYNVINOLIN ; SIMVOGET ; SIMCARD ; ZOCOR ; [8-[2-(4-HYDROXY-6-OXO-TETRAHYDROPYRAN-2-YL)ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]2,2-DIMETHYLBUTANOATE ; SIMVASTATIN, 99+% ; LIPONORM ; 8-[2-(4-HYDROXY-6-OXOTETRAHYDRO-2H-PYRAN-2-YL)ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRO-1-NAPHTHALENYL 2,2-DIMETHYLBUTANOATE ; SIMLUP ; 2,2-DIMETHYL-BUTYRIC ACID (1S,3R,7S,8S,8AR)-8-[2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRO-NAPHTHALEN-1-YL ESTER ; (1S,3R,7S,8S,8AR)-8-(2-[(2R,4R)-4-HYDROXY-6-OXOOXAN-2-YL]ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2,2-DIMETHYLBUTANOATE ; 2,2-DIMETHYL-1S,2,3R,7S,8S,8AR-HEXAHYDRO-3,7-DIMETHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENYL ESTER, BUTANOIC ACID ; SIMVACOR |
| pro_mdlNumber： | MFCD00072007 |
| pro_acceptors： | 5 |
| pro_donors： | 1 |
| pro_smile： | CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C |
| InChi： | InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1 |
| InChiKey： | InChIKey=RYMZZMVNJRMUDD-HGQWONQESA-N |
property |
|
| MeltingPoint： | 127-132 DEG C(LIT) |
| Comments： | BIOCHEM/PHYSIOL ACTIONS: SIMVASTATIN IS A SPECIFIC INHIBITOR OF HMG-COA REDUCTASE, THE ENZYME THAT CATALYZES THE CONVERSION OF HMG-COA TO MEVALONATE, AN EARLY STEP IN CHOLESTEROL BIOSYNTHESIS. IT IS USED IN THE TREATMENT OF HYPERCHOLESTEROLEMIA, AS IT REDUCES LEVELS OF LOW-DENSITY LIPOPROTEINS AND TRIGLYCERIDES, AND RAISES HIGH-DENSITY LIPOPROTEIN LEVELS. SIMVASTATIN IS A LACTONE THAT IS READILY HYDROLYZED IN VIVO TO THE CORRESPONDING BETA-HYDROXYACID, AND CAN BE ACTIVATED PRIOR TO USE WITH NAOH IN ETOH TREATMENT. IT IS A SYNTHETIC ANALOG OF LOVASTATIN (CAT NO M2147) GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA OTHER NOTES: SALES RESTRICTIONS MAY APPLY |
secure_info |
|
| secure_wgk_germany： | 2 |
* If the product has intellectual property rights, a license granted is must or contact us.
2010-2025 © Chemical Cloud Database. ALL Rights Reserved.浙ICP备11020424号-1
浙公网安备 33010802004002号
English